ARHGDIB

Rho GDP-dissociation inhibitor 2 · P52566 · ARHGDIB on Sugi Atlas →

0 patent compounds predicted against ARHGDIB, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to ARHGDIB by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
CB-PRP in Retinitis Pigmentosa and Dry Age-related Macular Degeneration PHASE3COMPLETED
Simvastatin + Cetuximab/Irinotecan in K-ras Mutant Colorectal Cancer (CRC) PHASE2COMPLETED
Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer PHASE2COMPLETED
A Clinical Study on Fasudil Hydrochloride for Treatment of Gene-Specific Ovarian Cancer PHASE2RECRUITING
A Phase 2 Study of Farnesyl Transferase Inhibitor (R115777, Tipifarnib) in Patients With Refractory or Relapsed Acute Myeloid Leukemia. PHASE2COMPLETED
Study in Adult Ph-positive ALL PHASE2UNKNOWN
Interleukin-2 Treatment for Wiskott-Aldrich Syndrome PHASE1COMPLETED
FAK Inhibitor in Patients With Advanced Solid Tumors PHASE1NOT_YET_RECRUITING
Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors PHASE1SUSPENDED
Gemcitabine and Dasatinib in Advanced Solid Tumors PHASE1COMPLETED
Expression and Function of the Renin-Angiotensin System in the Esophagus EARLY_PHASE1COMPLETED
ADRB3, ROCK2 and GEF Levels in Overactive Bladder Patients nanCOMPLETED
Study of the Pathophysiological Mechanisms Involved in Bleeding Events nanCOMPLETED
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Transcranial Magnetic Stimulation (TMS) Studies of Dystonia nanCOMPLETED
Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA nanRECRUITING
IVM for Patients With Low Ovarian Response. Does it Improve IVFoutcomes and Does it Improve the Following IVF Cycle? nanUNKNOWN
Genetics and Psychopathology in the 22q11 Deletion Syndrome nanUNKNOWN
Family Myopia Study nanCOMPLETED
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis) nanCOMPLETED
Gene Analysis of Parkinson's Disease nanCOMPLETED
Identification of an Asthma Susceptibility Gene on 3P nanCOMPLETED
Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles nanACTIVE_NOT_RECRUITING
Prospective Validation of a DNA Damage Repair-Hippo Pathway Signature in Patients With Advanced Gastric Cancer nanUNKNOWN
Role of Polymorphisms in the IL-1 Gene Cluster nanCOMPLETED
Investigating the Genetic Basis of Pseudoexfoliation Syndrome, Angle-closure Glaucoma and Primary Open-angle Glaucoma nanRECRUITING
Registry and Natural History of Epilepsy-Dyskinesia Syndromes nanRECRUITING
Relationship Between Genes Important in Blood Pressure Regulation and Blood Pressure Therapy in Hypertension nanCOMPLETED
Genetic Study of Patients With Primary Ciliary Dyskinesia nanCOMPLETED
CaREFREE Study (Calorie Restriction, Environment and Fitness: Reproductive Effects Evaluation Study) nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a ARHGDIB binder may also engage these)

ProteinNameSimilarity
Q61599 1.000 Q61599 →
Q9TU03 0.999 Q9TU03 →
PRMT5 Protein arginine N-methyltransferase 5 0.966 landscape →
P79260 0.966 P79260 →
Q9NYL9 0.965 Q9NYL9 →
Q9JKK7 0.965 Q9JKK7 →
A7YW45 0.965 A7YW45 →
Q9NZR1 0.964 Q9NZR1 →
Q9JLH8 0.964 Q9JLH8 →
Q5ZIN1 0.963 Q5ZIN1 →
Q9JHJ0 0.963 Q9JHJ0 →
Q6GNS3 0.963 Q6GNS3 →
A0JNC0 0.963 A0JNC0 →
Q8CIG8 0.963 Q8CIG8 →
PLCB1 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 0.963 landscape →
P70567 0.963 P70567 →
P28289 0.962 P28289 →
P70566 0.962 P70566 →
P49813 0.962 P49813 →
Q5R698 0.961 Q5R698 →
P51432 0.961 P51432 →
Q8K339 0.961 Q8K339 →
Q4R5M3 0.961 Q4R5M3 →
Q6NUA1 0.960 Q6NUA1 →
Q5RGJ5 0.960 Q5RGJ5 →
O93257 0.959 O93257 →
P45437 0.959 P45437 →
Q0P448 0.959 Q0P448 →
Q17QG2 0.959 Q17QG2 →
Q1JQD4 0.959 Q1JQD4 →